HHealth Read More Tirzepatide cuts fat mass by 35% while preserving skeletal muscleOctober 5, 2026 Six months of real-world treatment reveals how weight, fat mass, skeletal muscle, and metabolic health change in adults…
MMedication Read More Research makes strong case for broader use of GLP1 drugs to protect heartsSeptember 29, 2026 New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD)…
MMedication Read More GLP-1 drugs appear psychiatrically safe, but one finding still raises questionsSeptember 7, 2026 With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
HHealth Read More Experts call for safer weight loss as concerns grow over GLP-1 useAugust 31, 2026 Japanese cases of ketosis and ketoacidosis are prompting a closer look at how GLP-1 medications, restrictive dieting, and…
HHealth Read More Semaglutide dose may matter more than weight loss for heart healthJuly 15, 2026 A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
HHealth Read More Gut microbes emerge as potential players in estrogen-driven cancersJune 27, 2026 Scientists say gut microbes may do more than recycle estrogen, but turning the endocrine-microbiome axis into a cancer…
MMedication Read More The next goal for weight loss drugs? Fewer injectionsJune 9, 2026 For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
HHealth Read More People judge weight loss more harshly when GLP-1 drugs are involved, study findsApril 24, 2026 Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
GGenetics Read More Genetic modification enhances “living drugs” for blood cancersSeptember 25, 2025 CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
GGenetics Read More Genetic study shows dual GIPR/GLP1R action curbs binge alcohol useSeptember 15, 2025 New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
GGenetics Read More Genetic variants mimicking IL-6 inhibition linked to lower cardiovascular riskAugust 26, 2025 People with lower interleukin-6 activity have a reduced risk of cardiovascular diseases, a new LMU study reveals. Lowering…
GGenetics Read More Genetic variants influencing vitamin D synthesis, metabolism, and transportAugust 21, 2025 From skin tone to rare mutations, scientists uncover how your genes influence vitamin D levels, and why standard…